BioMOBIUS™ Research Platform Allows Sophisticated Technology Solutions for Biomedical Research

TRIL (Technology Research for Independent Living) CentreTRIL (Technology Research for Independent Living) Centre launched the BioMOBIUS™ Research Platform, an open shareable technology platform, which allows researcher to rapidly develop sophisticated technology solutions for biomedical research. This platform helps researchers to reduce the time spent on developing foundational technologies, allowing them to focus on their actual research.

The software elements of BioMOBIUS™ provide:

  • Rapid Development (Graphical Development Environment)
  • Biosignal Processing Applications (Real Time)
  • Mobile hardware and physiological sensor support
  • Straightforward user interfaces (GUI Designer)
  • Reduced Development Replication (Re-use of Blocks)
  • Targeting applications

The BioMOBIUS Research Platform was developed by the TRIL Centre, a groundbreaking research collaboration between Intel Corporation and a number of Irish academic partners, and jointly funded by Intel and the Industrial Development Agency (IDA) Ireland. Its goal is to explore technology to help older people to continue living independently. The platform is being used primarily by TRIL researchers to help clinicians detect and prevent or alleviate certain conditions related to ageing, such as falls and cognitive decline, and to help older people to strengthen their social connections.

The hardware elements of the BioMOBIUS™ research platform provide support for the SHIMMER wireless sensor platform and other third party hardware and sensor devices.

BioMOBIUS™ is freely available to users for research purposes only. Please follow the links to the register and download pages to obtain a copy of the BioMOBIUS™ software environment. Details on hardware support and availability can be found in the hardware section. Please feel to share your experiences of MOBIUS and suggestions for enhancements and new features via the provided discussion forum.

For further information, please visit:
http://biomobius.trilcentre.org

Related news articles:

About the TRIL Centre
The TRIL Centre is a multi-million euro research collaboration between industry and academic partners including Intel, University College Dublin, Trinity College Dublin and the National University of Ireland, Galway. The Centre has created dedicated laboratories at Intel and in each of the universities involved, and is driving bi-directional knowledge and technology transfer of research that addresses the physical, cognitive and social consequences of ageing. The TRIL Centre is one of the largest research projects of its kind in the world. It will develop innovative technologies to help people 'age in place' wherever they choose to live. For more information, please visit www.trilcentre.org.

Most Popular Now

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

A Novel AI-Based Method Reveals How Cell…

Researchers from Tel Aviv University have developed an innovative method that can help to understand better how cells behave in changing biological environments, such as those found within a cancerous...